ClinicalTrials HQ

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

Recruiting · NCT04428554 · Registry updated 2025-11-18
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic TherapyUrothelial Bladder CancerRecruitingPhase 22025-11-18NCT04428554

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Institut Claudius Regaud39

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Antoine LacassagneNiceFrance60
Centre Francois BaclesseCaenFrance19
Centre Jean PerrinClermont-FerrandFrance37
Centre Oscar LambretLilleFrance61
CHRU BrestBrestFrance21
CHU BesançonBesançonFrance32
Clinique Claude BernardAlbiFrance4
Clinique Pasteur-LanrozeBrestFrance2
Groupe Hospitalier Paris Saint-JosephParisFrance3
Groupement de Radiothérapie et d'Oncologie des PyrénéesPauFrance1
HIA BéginSaint-MandéFrance1
Institut Andrée DutreixDunkirkFrance2
Institut BergonieBordeauxFrance26
Institut CurieParisFrance44
Institut de Cancerologie de L'OuestSaint-HerblainFrance7
Institut de Cancerologie de L'OuestAngersFrance1
Institut de Cancerologie Lucien NeuwirthSaint-Priest-en-JarezFrance1
Institut Gustave RoussyVillejuifFrance58
Institut Paoli-CalmettesMarseilleFrance23
Institut Universitaire du Cancer Toulouse OncopoleToulouseFrance2